Aurinia Pharmaceuticals Inc (AUPH) Social Stream



Aurinia Pharmaceuticals Inc (AUPH): $9.21

0.16 (+1.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AURINIA PHARMACEUTICALS INC (AUPH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AUPH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 8 $40 $26 $34.125 $9.05 277.07%
2021-12-10 8 $40 $26 $33.875 $9.05 274.31%
2022-01-09 8 $40 $26 $33.625 $9.05 271.55%
2022-02-10 7 $40 $26 $33.625 $9.05 271.55%
2022-03-01 8 $34 $23 $31.125 $9.05 243.92%
2022-03-09 8 $34 $18 $27.437 $9.05 203.17%
2022-04-25 7 $34 $18 $26.5 $9.05 192.82%
2022-04-28 8 $34 $18 $25.937 $9.05 186.6%
2022-05-11 8 $30 $15 $23.812 $9.05 163.12%
2022-07-27 8 $30 $15 $23.312 $9.05 157.59%
2022-08-05 8 $30 $15 $23.187 $9.05 156.21%
2022-08-08 8 $30 $13 $22.437 $9.05 147.92%
2022-08-09 8 $30 $13 $21.312 $9.05 135.49%
2022-11-04 8 $30 $10 $19.062 $9.05 110.63%
2022-11-07 8 $15 $5.5 $11.875 $9.05 31.22%
2023-01-04 8 $15 $5.5 $12.187 $9.05 34.66%
2023-01-13 8 $15 $5.5 $12.562 $9.05 38.81%

The Trend in the Analyst Price Target


AUPH's average price target has moved down $13.94 over the prior 44 weeks.

AUPH reports an average of 145.03% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-01 8 34 18.0 28.875 12.01 140.42%
2022-04-25 8 34 18.0 26.500 11.39 132.66%
2022-04-25 7 34 18.0 26.500 11.39 132.66%
2022-05-11 8 30 18.0 24.437 9.58 155.08%
2023-01-13 8 15 5.5 12.562 9.11 37.89%

AUPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 4 2 2 0 0 8

The Trend in the Broker Recommendations


Over the past 48 weeks, AUPH's average broker recommendation rating worsened by 0.61.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, AURINIA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1676.25% of them.
  • AURINIA PHARMACEUTICALS INC's average analyst price target is greater than 624.48% of all US stocks.
  • In the context of all US stocks, AURINIA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1311.85% of them.
  • AURINIA PHARMACEUTICALS INC's number of analysts covering the stock is greater than 1322.52% of Pharmaceutical Products stocks.

Stocks similar to AURINIA PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HCM, MYOV, and ORGO.

Is AUPH a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7654 seconds.